Back
CBRE Global Real Estate Income Fund Vs. Tonix Pharmaceuticals Holding Corp. Industry Stock Comparison
Sell
39
IGR
CBRE Global Real Estate Income Fund
Last Price:
$4.29
Seasonality Move:
-0.18%
Sell
29
TNXP
Tonix Pharmaceuticals Holding Corp.
Last Price:
$17.13
Seasonality Move:
2.21%
Sell
39
CBRE Global Real Estate Income Fund (IGR)
is a Sell
Is CBRE Global Real Estate Income Fund a Buy, Sell or Hold?
-
The current CBRE Global Real Estate Income Fund [IGR] share price is $4.28. The Score for IGR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
IGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Tonix Pharmaceuticals Holding Corp. (TNXP)
is a Sell
Is Tonix Pharmaceuticals Holding Corp. a Buy, Sell or Hold?
-
The current Tonix Pharmaceuticals Holding Corp. [TNXP] share price is $17.09. The Score for TNXP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
TNXP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGR Stock Price Chart
What is CBRE Global Real Estate Income Fund's stock price today?
-
The CBRE Global Real Estate Income Fund share price today is $4.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGR is experiencing slight selling pressure.
TNXP Stock Price Chart
What is Tonix Pharmaceuticals Holding Corp.'s stock price today?
-
The Tonix Pharmaceuticals Holding Corp. share price today is $17.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNXP is experiencing selling pressure, which indicates risk of future bearish movement.
IGR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 33.26 | Sell |
| Chaikin Money Flow: | -336894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.31 - 4.65) | Sell |
| Bollinger Bands (100): | (4.6 - 5.12) | Sell |
TNXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.32 | Buy |
| Relative Strength Index (14 RSI): | 43.41 | Sell |
| Chaikin Money Flow: | -934278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.5 - 19.18) | Sell |
| Bollinger Bands (100): | (14.97 - 36.13) | Sell |
IGR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.29 | Sell |
| 20-day SMA: | 4.43 | Sell |
| 50-day SMA: | 4.7 | Sell |
| 200-day SMA: | 4.96 | Sell |
| 8-day EMA: | 4.32 | Sell |
| 20-day EMA: | 4.42 | Sell |
| 50-day EMA: | 4.54 | Sell |
| 200-day EMA: | 3.05 | Buy |
TNXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.68 | Sell |
| 20-day SMA: | 17.61 | Sell |
| 50-day SMA: | 18.01 | Sell |
| 200-day SMA: | 26.98 | Sell |
| 8-day EMA: | 9.36 | Buy |
| 20-day EMA: | 4.6 | Buy |
| 50-day EMA: | 2.01 | Buy |
| 200-day EMA: | 0.52 | Buy |
CBRE Global Real Estate Income Fund Earnings Growth & IGR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tonix Pharmaceuticals Holding Corp. Earnings Growth & TNXP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.85 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.86 per share, and an increase next year of $4.76 per share.
CBRE Global Real Estate Income Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tonix Pharmaceuticals Holding Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||